Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

Casco, N.; Jorge, A.L.; Palmero, D.J.; Alffenaar, J.W.; Fox, G.J.; Ezz, W.; Cho, J.G.; Denholm, J.; Skrahina, A.; Solodovnikova, V.; Arbex, M.A.; Alves, T.; Rabahi, M.F.; Pereira, G.R.; Sales, R.; Silva, D.R.; Saffie, M.M.; Salinas, N.E.; Miranda, R.C.; Cisterna, C.; Concha, C.; Fernandez, I.; Villalón, C.; Vera, C.G.; Tapia, P.G.; Cancino, V.; Carbonell, M.; Cruz, A.; Muñoz, E.; Muñoz, C.; Navarro, I.; Pizarro, R.; Cristina Sánchez, G.P.; Vergara Riquelme, M.S.; Vilca, E.; Soto, A.; Flores, X.; Garavagno, A.; Bahamondes, M.H.; Merino, L.M.; Pradenas, A.M.; Revillot, M.E.; Rodriguez, P.; Salinas, A.S.; Taiba, C.; Valdés, J.F.; Subiabre, J.N.; Ortega, C.; Palma, S.; Castillo, P.P.; Pinto, M.; Bidegain, F.R.; Venegas, M.; Yucra, E.; Li, Y.; Cruz, A.; Guelvez, B.; Victoria Plaza, R.; Tello Hoyos, K.Y.; Cardoso-Landivar, J.; Van Den Boom, M.; Andréjak, C.; Blanc, F.X.; Dourmane, S.; Froissart, A.; Izadifar, A.; Rivière, F.; Schlemmer, F.; Manika, K.; Diallo, B.D.; Hassane-Harouna, S.; Artiles, N.; Mejia, L.A.; Gupta, N.; Ish, P.; Mishra, G.; Patel, J.M.; Singla, R.; Udwadia, Z.F.; Alladio, F.; Angeli, F.; Calcagno, A.; Centis, R.; Codecasa, L.R.; De Lauretis, A.; Esposito, SMR; Formenti, B.; Gaviraghi, A.; Giacomet, V.; Goletti, D.; Gualano, G.; Matteelli, A.; Migliori, G.B.; Motta, I.; Palmieri, F.; Pontali, E.; Prestileo, T.; Riccardi, N.; Saderi, L.; Saporiti, M.; Sotgiu, G.; Spanevello, A.; Stochino, C.; Tadolini, M.; Torre, A.; Villa, S.; Visca, D.; Kurhasani, X.; Furjani, M.; Rasheed, N.; Danila, E.; Diktanas, S.; Ridaura, R.L.; Luna López, F.L.; Torrico, M.M.; Rendon, A.; Akkerman, O.W.; Chizaram, O.; Al-Abri, S.; Alyaquobi, F.; Althohli, K.; Aguirre, S.; Teixeira, R.C.; De Egea, V.; Irala, S.; Medina, A.; Sequera, G.; Sosa, N.; Vázquez, F.; Llanos-Tejada, F.K.; Manga, S.; Villanueva-Villegas, R.; Araujo, D.; Sales Marques, R.D.; Socaci, A.; Barkanova, O.; Bogorodskaya, M.; Borisov, S.; Mariandyshev, A.; Kaluzhenina, A.; Vukicevic, T.A.; Stosic, M.; Beh, D.; Ng, D.; Ong, CWM; Solovic, I.; Dheda, K.; Gina, P.; Caminero, J.A.; De Souza Galvão, M.L.; Dominguez-Castellano, A.; García-García, J.M.; Pinargote, I.M.; Fernandez, S.Q.; Sánchez-Montalvá, A.; Huguet, E.T.; Murguiondo, M.Z.; Bart, P.A.; Mazza-Stalder, J.; D'Ambrosio, L.; Kamolwat, P.; Bakko, F.; Barnacle, J.; Bird, S.; Brown, A.; Chandran, S.; Killington, K.; Man, K.; Papineni, P.; Ritchie, F.; Tiberi, S.; Utjesanovic, N.; Zenner, D.; Hearn, J.L.; Heysell, S.; Young, L.

doi:10.1183/13993003.00925-2023

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

Détails

Demande d'une copie Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: Final published version
Licence: Non spécifiée

ID Serval

serval:BIB_C73E5F757E12

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.

Périodique

The European respiratory journal

Auteur⸱e⸱s

Casco N., Jorge A.L., Palmero D.J., Alffenaar J.W., Fox G.J., Ezz W., Cho J.G., Denholm J., Skrahina A., Solodovnikova V., Arbex M.A., Alves T., Rabahi M.F., Pereira G.R., Sales R., Silva D.R., Saffie M.M., Salinas N.E., Miranda R.C., Cisterna C., Concha C., Fernandez I., Villalón C., Vera C.G., Tapia P.G., Cancino V., Carbonell M., Cruz A., Muñoz E., Muñoz C., Navarro I., Pizarro R., Cristina Sánchez G.P., Vergara Riquelme M.S., Vilca E., Soto A., Flores X., Garavagno A., Bahamondes M.H., Merino L.M., Pradenas A.M., Revillot M.E., Rodriguez P., Salinas A.S., Taiba C., Valdés J.F., Subiabre J.N., Ortega C., Palma S., Castillo P.P., Pinto M., Bidegain F.R., Venegas M., Yucra E., Li Y., Cruz A., Guelvez B., Victoria Plaza R., Tello Hoyos K.Y., Cardoso-Landivar J., Van Den Boom M., Andréjak C., Blanc F.X., Dourmane S., Froissart A., Izadifar A., Rivière F., Schlemmer F., Manika K., Diallo B.D., Hassane-Harouna S., Artiles N., Mejia L.A., Gupta N., Ish P., Mishra G., Patel J.M., Singla R., Udwadia Z.F., Alladio F., Angeli F., Calcagno A., Centis R., Codecasa L.R., De Lauretis A., Esposito SMR, Formenti B., Gaviraghi A., Giacomet V., Goletti D., Gualano G., Matteelli A., Migliori G.B., Motta I., Palmieri F., Pontali E., Prestileo T., Riccardi N., Saderi L., Saporiti M., Sotgiu G., Spanevello A., Stochino C., Tadolini M., Torre A., Villa S., Visca D., Kurhasani X., Furjani M., Rasheed N., Danila E., Diktanas S., Ridaura R.L., Luna López F.L., Torrico M.M., Rendon A., Akkerman O.W., Chizaram O., Al-Abri S., Alyaquobi F., Althohli K., Aguirre S., Teixeira R.C., De Egea V., Irala S., Medina A., Sequera G., Sosa N., Vázquez F., Llanos-Tejada F.K., Manga S., Villanueva-Villegas R., Araujo D., Sales Marques R.D., Socaci A., Barkanova O., Bogorodskaya M., Borisov S., Mariandyshev A., Kaluzhenina A., Vukicevic T.A., Stosic M., Beh D., Ng D., Ong CWM, Solovic I., Dheda K., Gina P., Caminero J.A., De Souza Galvão M.L., Dominguez-Castellano A., García-García J.M., Pinargote I.M., Fernandez S.Q., Sánchez-Montalvá A., Huguet E.T., Murguiondo M.Z., Bart P.A., Mazza-Stalder J., D'Ambrosio L., Kamolwat P., Bakko F., Barnacle J., Bird S., Brown A., Chandran S., Killington K., Man K., Papineni P., Ritchie F., Tiberi S., Utjesanovic N., Zenner D., Hearn J.L., Heysell S., Young L.

Collaborateur⸱rice⸱s

Global Tuberculosis Network and TB/COVID-19 Global Study Group

ISSN

1399-3003 (Electronic)

ISSN-L

0903-1936

Statut éditorial

Publié

Date de publication

11/2023

Peer-reviewed

Oui

Volume

Numéro

Pages

2300925

Langue

anglais

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish

Résumé

Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19.
We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end of cohort time. All patients had TB and COVID-19; for analysis purposes, deaths were attributed to TB, COVID-19 or both. Survival analysis was performed using Cox proportional risk-regression models, and the log-rank test was used to compare survival and mortality attributed to TB, COVID-19 or both.
Overall, 788 patients with COVID-19 and TB (active or sequelae) were recruited from 31 countries, and 10.8% (n=85) died during the observation period. Survival was significantly lower among patients whose death was attributed to TB and COVID-19 versus those dying because of either TB or COVID-19 alone (p<0.001). Significant adjusted risk factors for TB mortality were higher age (hazard ratio (HR) 1.05, 95% CI 1.03-1.07), HIV infection (HR 2.29, 95% CI 1.02-5.16) and invasive ventilation (HR 4.28, 95% CI 2.34-7.83). For COVID-19 mortality, the adjusted risks were higher age (HR 1.03, 95% CI 1.02-1.04), male sex (HR 2.21, 95% CI 1.24-3.91), oxygen requirement (HR 7.93, 95% CI 3.44-18.26) and invasive ventilation (HR 2.19, 95% CI 1.36-3.53).
In our global cohort, death was the outcome in >10% of patients with TB and COVID-19. A range of demographic and clinical predictors are associated with adverse outcomes.

Mots-clé

Humans, Male, COVID-19/complications, HIV Infections/complications, Coinfection, Risk Factors, Tuberculosis, Miliary, Retrospective Studies

OAI-PMH

oai:serval.unil.ch:BIB_C73E5F757E12

DOI

10.1183/13993003.00925-2023

Pubmed

37827576

Web of science

001118974500008

Open Access

Oui